New gel offers hope for aching knees
NCT ID NCT06693648
Summary
This study is testing whether a daily gel called AMZ001 can safely reduce pain and other symptoms of knee osteoarthritis. About 540 adults with moderate knee arthritis will apply the gel or a placebo to one knee for six weeks. Researchers will measure changes in pain levels to see if the gel works better than the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charles University
Prague, Czechia
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
-
DelRicht Research
Rockville, Maryland, 20852, United States
-
Eastern Research Inc
Hialeah, Florida, 33013, United States
-
Future Medical Research
Longwood, Florida, 32750, United States
-
Medyczne Centrum Hetmanska Piotr Leszczynski
Poznan, Poland
-
Millennium Clinical Trials
Thousand Oaks, California, 91360, United States
-
Oakland Medical Research
Troy, Michigan, 48085, United States
-
Sanos Clinic
Herlev, Denmark
-
West Clinical Research
Morehead City, North Carolina, 28557, United States
-
hong Kong Center for Clinical Research
Hong Kong, China
Conditions
Explore the condition pages connected to this study.